Cargando…

Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653076/
https://www.ncbi.nlm.nih.gov/pubmed/31339669
http://dx.doi.org/10.1111/jcmm.14431
_version_ 1783438580627013632
collection PubMed
description
format Online
Article
Text
id pubmed-6653076
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66530762019-10-01 Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1 J Cell Mol Med Retraction John Wiley and Sons Inc. 2019-07-24 2019-08 /pmc/articles/PMC6653076/ /pubmed/31339669 http://dx.doi.org/10.1111/jcmm.14431 Text en © 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
title Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
title_full Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
title_fullStr Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
title_full_unstemmed Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
title_short Retracted: MicroRNA‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1
title_sort retracted: microrna‐224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting rac1
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653076/
https://www.ncbi.nlm.nih.gov/pubmed/31339669
http://dx.doi.org/10.1111/jcmm.14431